✓ Medically reviewed by · Last reviewed: May 2026
Pharmacy Researcher · 8 years experience
Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.
Key Takeaways — Finpecia vs Propecia
- Both contain finasteride 1 mg — the same molecule, the same dose. The clinical effect on hair regrowth and DHT suppression is identical.
- Propecia is the original brand from Merck (FDA-approved 1997). Finpecia is the most widely used generic, manufactured by Cipla Limited in India under WHO-GMP.
- Cost is the only meaningful difference: Propecia 1 mg runs ~$70–$110/month at US retail; Finpecia from international generic pharmacies typically lands at $15–$20 for a 100-tablet supply (roughly 3 months).
- Side effect profile is the same for both — including the well-known sexual side effects (in 1–4% of users) and the rare “post-finasteride syndrome” that has prompted ongoing safety review.
- Propecia’s patent expired in 2014 in the US; generic finasteride 1 mg is now widely available domestically. The decision is brand-loyalty and supply preference rather than clinical superiority.
The 60-Second Comparison
Propecia is the brand name under which Merck & Co. sells finasteride 1 mg specifically for male pattern hair loss (androgenetic alopecia). The same molecule at 5 mg dose is sold by Merck as Proscar for benign prostatic hyperplasia. Finpecia is the generic finasteride 1 mg manufactured by Cipla, one of the largest pharmaceutical companies in India and a long-standing supplier to regulated markets including the US (Cipla’s plants are USFDA-inspected and approved for export).
Patent on finasteride expired in 2014 in the US and earlier in many other markets. Since then, dozens of generic manufacturers have launched 1 mg finasteride tablets globally. Finpecia is the dominant Indian-market brand by volume, but functionally equivalent products include Cipla’s own Hair4U range, Sun Pharma’s Finalo, and several smaller-volume manufacturers’ offerings.
Head-to-Head: Finpecia vs Propecia
| Feature | Finpecia (generic) | Propecia (brand) |
|---|---|---|
| Active ingredient | Finasteride 1 mg | Finasteride 1 mg |
| Manufacturer | Cipla Limited (WHO-GMP) | Merck & Co. |
| FDA approval | Generic; approved as bioequivalent in markets that recognise Indian Pharmacopoeia | FDA-approved 1997 for male pattern hair loss |
| Mechanism | 5-alpha reductase type II inhibitor | 5-alpha reductase type II inhibitor |
| DHT suppression | ~70% scalp DHT reduction; ~65% serum DHT reduction | ~70% scalp DHT reduction; ~65% serum DHT reduction |
| Standard dose | 1 mg once daily | 1 mg once daily |
| Half-life | ~5–6 hours (8 hours in older men) | ~5–6 hours (8 hours in older men) |
| Time to visible result | 3–6 months (early); 12 months (full effect) | 3–6 months (early); 12 months (full effect) |
| Approved for women? | No — pregnancy contraindicated; off-label use in postmenopausal female pattern hair loss | No — same pregnancy contraindication; off-label use in some women |
| Tablet count per pack | 10, 30, 100, 150 (depending on supplier) | 28, 84 typically |
| Cost (US retail / equivalent) | ~$15–$25 / 100 tabs (~$0.20/day) | $70–$110 / 30 tabs (~$2–$3/day) |
| Annual cost | ~$70–$90/year | ~$840–$1,300/year |
Bioequivalence: Are They Really Identical?
Bioequivalence between Finpecia and Propecia rests on three independently verifiable pillars:
- The active molecule is finasteride. Finasteride is a single, well-characterised chemical entity (4-azasteroid). The synthesis route doesn’t affect the final molecule’s pharmacology. Both Cipla and Merck manufacture finasteride to the same chemical purity specification.
- The dose is 1 mg. Verified against tablet weight and HPLC content uniformity testing — standard quality control at any WHO-GMP plant. Cipla publishes Certificates of Analysis for each batch.
- Bioequivalence (BE) studies have been conducted. Generic finasteride was approved by the US FDA in 2013 on the basis of standard BE testing showing 80–125% AUC and Cmax range vs the reference Propecia — the standard regulatory threshold. Cipla’s product specifically has been used in regulated markets across Europe and Asia for over a decade.
What does NOT typically differ: clinical effect on hair regrowth, DHT suppression, side-effect rate, or treatment-failure rate. Independent dermatology practices that have switched patients between brand and generic finasteride report identical clinical outcomes.
What CAN differ: tablet hardness (Cipla’s Finpecia uses a slightly different excipient mix), dyes (Propecia is octagonal and brown-coated; Finpecia is a smaller white tablet), lactose content for lactose-sensitive users, and shelf-life dating. None affect the drug’s clinical effect.
What Finasteride Does and Does Not Do
Finasteride is a competitive inhibitor of 5-alpha reductase type II — the enzyme that converts testosterone to dihydrotestosterone (DHT) in scalp follicles, prostate, and seminal vesicles. By suppressing DHT (~70% in the scalp, ~65% in serum), finasteride halts the miniaturisation of genetically susceptible hair follicles in androgenetic alopecia.
What it does:
- Halts further hair loss in roughly 80–90% of men with androgenetic alopecia (the strongest evidence base in dermatology for this indication)
- Regrows visible hair in 30–60% of men, particularly in the vertex (crown) — less reliably at the temporal hairline
- Continues working as long as you take it. Full effect takes 12 months. Discontinuation reverses the gains over 6–12 months
What it does NOT do:
- Reverse follicles that are dead. Finasteride works on miniaturised but still-living follicles. Bald patches with no remaining peach-fuzz hair will not regrow
- Work for non-androgenetic hair loss — alopecia areata, telogen effluvium, scarring alopecias, and traction alopecia are not finasteride-responsive
- Substitute for minoxidil. Combining finasteride with topical minoxidil (Tugain Foam, Tugain Solution) produces meaningfully better results than finasteride alone — the two drugs work on different parts of the same problem
Side Effects: Same for Both Brands
The side-effect profile is finasteride’s most-discussed feature, particularly the sexual side effects. The data is the same regardless of brand.
| Effect | Reported rate | Notes |
|---|---|---|
| Decreased libido | ~1.8% (vs ~1.3% placebo in trial) | Most resolve with continued use or discontinuation |
| Erectile dysfunction | ~1.3% (vs ~0.7% placebo) | Usually mild; reversible on discontinuation |
| Reduced ejaculate volume | ~1.2% (vs ~0.7% placebo) | Reflects DHT-dependent seminal-vesicle function |
| Gynecomastia | ~1% (with long-term use) | Breast tissue enlargement; investigate any breast lump |
| Mood changes / depression | Less common; signal in post-marketing surveillance | Watch for mood low or anxiety in first months |
| Persistent post-finasteride syndrome (PFS) | Rare but disputed | Sexual / cognitive / mood symptoms persisting after discontinuation; under FDA and EMA review |
| Reduced PSA | Universal | Halves PSA — flag this if your doctor checks PSA for prostate cancer screening |
Cost: The Practical Argument for Generic
The math is straightforward. A man starting finasteride for androgenetic alopecia can expect to take it indefinitely — discontinuation at any point reverses gains within a year. Annual cost over 20 years of treatment:
- Propecia (brand) at US retail: $70–$110/month × 12 × 20 = $16,800–$26,400 lifetime
- Finpecia or other WHO-GMP generic: $80/year × 20 = ~$1,600 lifetime
The active drug is the same. The clinical effect is the same. The 10–15× price difference is paid for the brand label, the marketing budget, and the supply chain that runs through US insurance carriers and retail pharmacies. For a chronic, lifelong treatment with no clinical advantage to the brand, the cost-rational choice is generic.
At MedsBase, Finpecia 1 mg by Cipla is the canonical generic finasteride product. For combination therapy with topical minoxidil, the Hair Loss Stack bundles a 3-month Finpecia supply with a 60 ml Tugain 5% foam at a discounted price.
🛡️ Every MedsBase order includes Reshipment Assurance — if your parcel doesn’t arrive, we reship at no extra cost.
Frequently Asked Questions
Is Finpecia the same as Propecia?
The active ingredient is the same — finasteride 1 mg. Both are 5-alpha reductase type II inhibitors used for male pattern hair loss. The clinical effect on hair regrowth and DHT suppression is identical. The differences are: Propecia is the original brand from Merck; Finpecia is a generic equivalent from Cipla. Tablet size, shape, and excipients differ slightly, but the drug delivered to the body is the same.
Is generic finasteride as effective as Propecia?
Yes. Bioequivalence studies submitted to the FDA in 2013 (when the generic was approved) showed that generic finasteride 1 mg falls within the 80–125% AUC and Cmax range of brand Propecia — the regulatory standard. Multiple independent dermatology practices have reported identical clinical outcomes when switching patients between brand and generic finasteride. Quality depends on whether the manufacturer meets pharmacopoeial standards, not on whether the box says Propecia.
How long does it take Finpecia or Propecia to work?
Early visible improvement (less shedding, slight regrowth in the crown) appears at 3–6 months. Full clinical effect, including stabilised hairline and maximal regrowth, is reached at about 12 months. Treatment duration matters: men who quit at 6 months because they “see no result” almost always lose what they have gained within a year. The 12-month commitment is the entry point.
Will I lose hair if I stop taking Finpecia?
Yes. Finasteride works as long as you take it. After discontinuation, scalp DHT levels return to baseline within weeks, and the protective effect on miniaturised follicles is lost over the following 6–12 months. Hair regained on treatment is usually lost again within a year of stopping. This is why finasteride is regarded as a lifelong commitment for men who choose to start.
Does Finpecia cause sexual side effects?
The reported rates in clinical trials are low — about 1–4% across libido reduction, erectile dysfunction, and reduced ejaculate volume — only marginally above placebo (1–2%). Most men experience no sexual side effects. Among those who do, most resolve either with continued use (the body adjusts) or with discontinuation. The brand of finasteride is irrelevant to side-effect rate; identical molecule, identical biology.
Can women take Finpecia or Propecia?
Finasteride is not approved for women, and pregnant or potentially-pregnant women must not handle broken tablets (risk of male fetal feminisation). For postmenopausal women with female pattern hair loss, off-label finasteride is sometimes prescribed at higher doses (2.5–5 mg) by dermatologists, with mixed evidence. Premenopausal women should not use finasteride.
Should I combine Finpecia with minoxidil?
Yes — the combination produces measurably better results than either drug alone. Finasteride works on the DHT pathway (reducing the cause of follicle miniaturisation); minoxidil works as a vasodilator and follicular growth stimulant (a complementary mechanism). Most dermatology guidelines recommend dual therapy for men serious about hair preservation. The Hair Loss Stack bundles both drugs at a discounted price, or you can buy Finpecia and Tugain Foam (5% minoxidil) separately.
What is post-finasteride syndrome (PFS)?
PFS is the term used for a constellation of sexual, cognitive, and mood symptoms reported by some men after discontinuing finasteride. It includes persistent erectile dysfunction, reduced libido, anhedonia, and brain fog lasting months or years after stopping the drug. The syndrome is recognised by the FDA on the Propecia label, has been formally studied at Northwestern, and remains under active research. The reported incidence is rare. Anyone considering finasteride should be aware of it before starting.
Does finasteride affect prostate cancer screening?
Yes. Finasteride approximately halves serum prostate-specific antigen (PSA). If you take finasteride and your doctor monitors PSA, the lab result must be doubled to compare to PSA reference ranges established in non-finasteride-using men. Tell any urologist or primary care physician that you are on finasteride — many lab reports do not flag this automatically.
Can I get Finpecia without a prescription?
In the United States, EU, and UK, finasteride is prescription-only. Internationally, regulatory pathways differ. Finpecia is available at MedsBase through licensed international generic pharmacy channels. For US-based supply, telehealth services (Hims, Roman, Keeps, etc.) provide low-cost finasteride after a brief online consultation — this is often the most convenient and cost-effective path within the US healthcare system.
Related guides: Finasteride vs Dutasteride: Which Works Better? · Best Finasteride Brands (2026): 10 Top Generics Compared · Best Hair Loss Treatments in 2026
Written by
Sophie ChenPharmaceutical Content Researcher · 8 years experience
Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.